Skip to main content
Industry Insights

Industry Insights · Medical Polymers & Silicone

Restricted vs unrestricted: how implant-grade medical silicone is split and chosen

When choosing implant-grade medical silicone, the first cut is restricted vs unrestricted. It is not marketing language — it maps to different depths of biocompatibility testing and regulatory pathway.

Published:2026-06-18Updated:2026-06-18

Updated
Diagram grading restricted vs unrestricted medical silicone by contact duration and biocompatibility
Medical materials are graded by where and how long they contact the body: surface, external path, implant; the longer and deeper the contact, the more stringent the biocompatibility testing. Illustrative.
In short: Restricted materials are for short-term implantation or surface/external contact (typically <=29 days) — syringe O-rings, lubricants, external devices, hearing-aid domes — with testing covering cytotoxicity, systemic/intracutaneous toxicity and a 7-day implant test. Unrestricted materials are for long-term or permanent implantation (>29 days) — pacemaker leads, cochlear implants, IOLs, breast implants, heart valves — adding deeper testing such as 12-week implant, hemolysis, genotoxicity, pyrogenicity and sensitization. In short: choose by contact duration — short-term/external use restricted, long-term implant use unrestricted.

The clean split: by contact duration

Restricted vs unrestricted is not about material quality but about qualification depth: the longer and deeper the contact, the more biocompatibility evidence required. 29 days is the common dividing line.

DimensionRestrictedUnrestricted
Contact duration<=29 days, short-term / external>29 days, long-term / permanent
Typical usesyringe O-rings, lubricants, external devices, hearing-aid domespacemaker leads, cochlear implants, IOLs, breast implants, heart valves
Biocompatibility testingcytotoxicity, systemic/intracutaneous toxicity, 7-day implantabove + 12-week implant, hemolysis, genotoxicity, pyrogenicity, sensitization
Regulatory filedevice master file + biocompatibility compendiummaster file + extended testing
Barrier / costlower, for limited usehigher

What is USP Class VI

Class VI is USP's stringent biocompatibility framework for plastics/elastomers, often including per-lot cytotoxicity, systemic/intracutaneous toxicity and a 7-day implant test. Important: passing Class VI / ISO 10993 does not equal device-level biocompatibility or approval — device-level testing and regulatory assessment are still required.

Mapping to MED grades

The table below shows representative classifications from training materials, for selection reference only; verify against current TDS and regulatory documentation:

Code rangeClassTypical use
MED-41xxHCR (restricted)External devices
MED-45xxHCR (restricted)Short-term implant
MED-48xxHCR (unrestricted)Long-term implant
MED-59xxLSR (restricted)Class VI devices
MED-60xxLCE / gelsSoft components / implant

The BIO angle

The right order for choosing implant-grade silicone is: first set restricted/unrestricted from contact site and duration, then match the MED grade, cure and citable supplier documentation (TDS / master-file info). This is exactly where BIO supports device makers — selection plus documentation to back your NMPA / ISO 10993 submission.

FAQ

How are restricted and unrestricted defined?

Mainly by contact/implant duration, with ~29 days as the line: <=29 days short-term/external uses restricted; >29-day long-term implants use unrestricted.

Can restricted materials be used for long-term implants?

Not advised. Long-term implants should use unrestricted grades and complete the corresponding long-term implant biocompatibility testing.

Does passing USP Class VI mean it can be implanted?

No. Class VI / ISO 10993 are material-level supporting tests; whether a device can be implanted still needs device-level testing and regulatory approval.

How does this relate to ISO 10993?

ISO 10993 specifies the biological evaluation needed by contact nature and duration; restricted/unrestricted correspond to different evaluation depths.

Can you provide documentation for submissions?

We can provide TDS and citable supplier master-file information, with material selection support for your NMPA submission; subject to current documentation.

Related reading

Browse all insights →

Note: an original analysis compiled from public industry information; figures and conclusions per official/original sources. Not investment advice.

Building in China's medical-device market?

From advanced medical silicone/polymers to material selection, regulatory and supply, BIO helps global and local partners move from selection to landed supply in China.